NAVIDEA BIOPHARMACEUTICALS, INC. reports

Company location: Dublin, OH
Fiscal year end: 31 December

NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 176-200 of 949 matching filings.

Per page

25

Current page

8

4

FORM 4

Filing date: 02 Dec 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Dec 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Dec 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Dec 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Dec 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Dec 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35076

FORM 8-K

Filing date: 26 Nov 2021
Reporting date: 23 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

3

FORM 3

Filing date: 12 Nov 2021
Reporting date: 07 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-35076

FORM 10-Q

Filing date: 12 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35076

FORM 8-K

Filing date: 10 Nov 2021
Reporting date: 10 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35076

FORM 8-K

Filing date: 26 Oct 2021
Reporting date: 24 Oct 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

3

FORM 3

Filing date: 19 Oct 2021
Reporting date: 07 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35076

FORM 8-K

Filing date: 14 Oct 2021
Reporting date: 07 Oct 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

3

FORM 3

Filing date: 05 Oct 2021
Reporting date: 01 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Oct 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Oct 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Oct 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35076

FORM 8-K

Filing date: 30 Sep 2021
Reporting date: 27 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 17 Sep 2021
Reporting date: 17 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35076

FORM 8-K

Filing date: 17 Sep 2021
Reporting date: 14 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-35076

FORM 10-Q

Filing date: 12 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35076

FORM 8-K

Filing date: 11 Aug 2021
Reporting date: 11 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-35076

FORM DEF 14A

Filing date: 02 Aug 2021
Reporting date: 14 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 26 Jul 2021
Reporting date: 26 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-43603

SC 13D/A

Filing date: 23 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .